Furthermore, reducing levels of miR-143-3p in mice through anti-miR-143-3p injection into the tail vein was found to mitigate obesity-induced insulin resistance by modulating the expression of the insulin-like growth factor-2 receptor (Igf2r) [203]. The gene discussed is IGF2R; the disease is obesity disorder.